Skip to main content
Clinical Trials/NCT00701844
NCT00701844CompletedNot Applicable

Sharing Our Strength: A Research Study for Bone Marrow/Stem Cell Transplant Survivors

University of North Carolina, Chapel Hill5 sites in 1 country315 target enrollmentStarted: July 2007Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
315
Locations
5
Primary Endpoint
Psychological Adjustment

Study Overview

Brief Summary

The Sharing Our Strength study is being conducted to help us understand people's experiences with hematopoietic stem cell transplantation and to test a new program designed to help people recover physically and emotionally after transplant.

Detailed Description

This is a study for survivors of hematopoietic stem cell transplantation (also known as bone marrow transplant), which is an intensive medical treatment for cancers such as leukemia, lymphoma, and multiple myeloma as well as other diseases. Because it is a physically and emotionally demanding treatment, many people report having ongoing physical and emotional difficulties after having a transplant. The Sharing Our Strength study is being conducted to help us understand people's transplant experiences and to test a new program designed to help them recover physically and emotionally after transplant. All parts of the study are completed by mail and telephone. Participants will receive compensation for their time.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Factorial
Primary Purpose
Treatment
Masking
Double (Participant, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Be a transplant survivor who is 9 months to 3 years beyond transplant and not currently relapsed. and not currently relapsed
  • Be at least 18 years old now (and at least 16 when they had their transplant)
  • Speak English
  • Have telephone service

Exclusion Criteria

  • Not provided

Arms & Interventions

Control writing type 1

Active Comparator

Intervention: Writing C (Control informative writing) (Behavioral)

Control writing type 2

Placebo Comparator

Intervention: Writing D (Control noninformative writing) (Behavioral)

Experimental Writing Type 1

Experimental

Intervention: Writing A (Experimental informative writing) (Behavioral)

Experimental Writing type 2

Experimental

Intervention: Writing B (Experimental noninformative writing) (Behavioral)

Outcomes

Primary Outcomes

Psychological Adjustment

Time Frame: At screening, baseline and 3 months following intervention

Secondary Outcomes

  • Quality of Life(At screening, baseline and 3 months following intervention)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (5)

Loading locations...

Similar Trials